Home Blog Page 1904

Seren Juno and RIBBON Achieve 20Tbps Transmission on 10,000 km JUNO Trans-Pacific Cable

By
Advertorial Desk
-

TOKYO, Nov. 19, 2025 /PRNewswire/ — Ribbon Communications Inc. (Nasdaq: RBBN), a global leader in real-time communications technology and IP optical networking solutions, today announced the successful completion of a 20Tbps optical transmission field trial on the 10,000 km JUNO trans-Pacific submarine cable, developed and operated by Seren Juno. Ribbon’s mission is to help service providers, enterprises and critical infrastructure operators worldwide modernize and secure their networks and services.

Set to become the largest trans-Pacific cable system between Japan and the U.S., JUNO will deliver more than 350Tbps of total capacity across 20 fiber pairs, supporting growing global demand for high-speed connectivity.

“This is a significant milestone in long-haul optical networking, confirming the feasibility of transmitting 20 terabits per second per fiber pair,” said Sam Bucci, Ribbon EVP and COO, Ribbon. “Our Apollo platform’s ability to deliver 20Tbps over 10,000 km showcases the scalability and robustness of Ribbon’s technology for next-generation global connectivity.”

“Achieving results that rival those of leading competitors gives us confidence that this could become one of our new strategic options,” said Yoshio Sato, CEO, Seren Juno.

The trial featured Ribbon’s Apollo 9408 transponder, powered by advanced 5nm 140GBaud technology, and the Apollo 9608 platform, which integrates submarine-grade optical line system functions. The Apollo 9408 supports flexible modulation from 400Gbps to 1.2Tbps per wavelength, enabling performance optimization tailored to cable conditions. Combined with the compact, low-power Apollo 9608, Ribbon sets a new benchmark for submarine optical transmission.

About Ribbon
Ribbon Communications (Nasdaq: RBBN) delivers secure cloud communications and IP and optical networking solutions to service providers, enterprises and critical infrastructure sectors globally. We engage deeply with our customers, helping them modernize their networks for improved competitive positioning and business outcomes in today’s smart, always-on and data-hungry world. Our end-to-end portfolio of communications software and IP Optical networking solutions delivers superior value and innovation by leveraging cloud-native architectures, automation and analytics tools, and leading-edge security. We maintain a keen focus on our commitments to Environmental, Social, and Governance (ESG) matters, offering an annual Sustainability Report to our stakeholders. To learn more about Ribbon, please visit rbbn.com

Important Information Regarding Forward-Looking Statements
The information in this release contains forward-looking statements regarding future events that involve risks and uncertainties. All statements other than statements of historical facts contained in this release, including those regarding the expected benefits from use of Ribbon Communication’s products, are forward-looking statements. The actual results of Ribbon Communications may differ materially from those contemplated by the forward-looking statements. For further information regarding risks and uncertainties associated with Ribbon Communications’ business, please refer to the “Risk Factors” section of Ribbon Communications’ most recent annual or quarterly report filed with the SEC. Any forward-looking statements represent Ribbon Communications’ views only as of the date on which such statement is made and should not be relied upon as representing Ribbon Communications’ views as of any subsequent date. While Ribbon Communications may elect to update forward-looking statements at some point, Ribbon Communications specifically disclaims any obligation to do so.

Investor Contact
+1 (978) 614-8050
ir@rbbn.com

Media Contact
Catherine Berthier
+1 (646) 741-1974
cberthier@rbbn.com 

About Seren Juno Network Co., Ltd.

Established in July 2022 as a joint venture between NTT Ltd. Japan Corporation, Mitsui & Co., Ltd., PC Landing Corp., and JA Mitsui Leasing, Ltd., Seren Juno Network Co., Ltd. is the owner and operator of the JUNO submarine cable system. JUNO is a next-generation trans-Pacific cable spanning approximately 10,000 km between Japan and the United States, featuring 20 fiber pairs (40 optical cores) and a design capacity of up to 350 Tbps. Seren Juno’s mission is to provide secure, scalable, and high-capacity international connectivity to meet the rapidly growing demands of the digital economy. For more information, please visit: https://www.seren-juno.com/.

Logo – https://laotiantimes.com/wp-content/uploads/2025/11/ribbon_logo.jpg 

Bitsight Reports 50% Growth in APAC Amid Rising Demand for Cyber Risk Intelligence

By
Advertorial Desk
-

Success of Luminate Exchange Japan underscores the company’s expanding presence and commitment to helping organizations across the region strengthen cyber resilience.

TOKYO, Nov. 19, 2025 /PRNewswire/ — Bitsight, the global leader in cyber risk intelligence, today announced continued momentum in Asia-Pacific following the successful conclusion of Luminate Exchange Japan 2025, the company’s flagship event for security and risk leaders. The event convened nearly 100 senior executives, government officials, and cybersecurity experts to discuss how organizations can strengthen resilience through intelligence-led visibility into cyber risk.

Bitsight achieved 50% year-over-year growth across APAC through the close of Q3 2025, driven by accelerating demand for cyber risk intelligence among enterprises and government organizations across the region. The momentum reflects Bitsight’s unique ability to integrate exposure management with real-time threat intelligence, empowering organizations to achieve contextualized risk prioritization and make faster, data-driven decisions across their extended attack surface.

Key Insights from Luminate Exchange Japan 2025

New research shared at the event revealed critical trends shaping Japan’s cybersecurity landscape:

  • High digital supply chain concentration: Japan’s digital supply chain has a unique profile with many providers supplying more than 50% of the Japanese market.
  • Elevated vulnerability rates: On average, Japanese companies experience 2.8x more total vulnerability findings per asset compared to the global average, and 2.9x more critical CVEs (CVSS ≥9).
  • Growing APT risk: Vulnerabilities with a high likelihood of exploitation by advanced persistent threats (APTs) occur 1.9x more often in Japanese organizations than elsewhere.

These findings highlight the importance of cyber risk intelligence as a foundation for national and enterprise resilience.

“Japan’s digital economy is rapidly expanding – and with it, the need for actionable intelligence about exposure and risk,” said Steve Harvey, CEO of Bitsight. “The success of Luminate Exchange Japan 2025 reflects a growing commitment among Japanese organizations to advance their cyber resilience. While they are among the most digitally advanced in the world, Japan’s highly concentrated digital supply chains, elevated rates of critical vulnerabilities, and heightened exposure to APT-linked threats demand a shift beyond compliance toward continuous, intelligence-driven visibility.”

Expanding Presence and Partnerships in Japan

Bitsight continues to strengthen its investment in Japan, expanding its Tokyo-based team, building partnerships with leading technology and security providers, and enhancing localized support for customers across sectors such as financial services, manufacturing, and technology.

“We’re proud to support leading Japanese brands such as Ricoh and Shiseido, along with innovators like Nomura Asset Management, who rely on Bitsight’s cyber risk intelligence to strengthen and secure their digital ecosystems – and, in the case of Nomura Asset Management, to make more informed fixed-income investment decisions,” said Kisso Diall, General Manager, APAC at Bitsight. “Our continued growth in APAC reflects a strong desire among organizations to better detect, prioritize, mitigate and communicate their cyber risk.”

About Bitsight
Bitsight is the global leader in cyber risk intelligence, leveraging advanced AI to empower organizations with precise insights derived from the industry’s most extensive external cybersecurity dataset. With more than 3,500 customers and over 68,000 organizations active on its platform, Bitsight delivers real-time visibility into cyber risk and threat exposure, enabling teams to rapidly identify vulnerabilities, detect emerging threats, prioritize remediation, and mitigate risks across their extended attack surface.

Bitsight proactively uncovers security gaps across infrastructure, cloud environments, digital identities, and third- and fourth-party ecosystems. From security operations and governance teams to executive boardrooms, Bitsight provides the unified intelligence backbone required to confidently manage cyber risk and address exposures before they impact performance.

For more information, visit bitsight.com, read our blog, or connect with us on LinkedIn.

Logo – https://laotiantimes.com/wp-content/uploads/2025/11/bitsight_logo.jpg 

 

Pony.ai Announces Gen-4 Autonomous Truck Lineup, Set for Mass Production and Deployment in 2026

By
Advertorial Desk
-

BEIJING, Nov. 19, 2025 /PRNewswire/ — Pony.ai, a global leader in autonomous driving technology, today announces its fourth-generation (Gen-4) autonomous truck lineup, jointly developed with manufacturing partners including SANY Truck.

The Gen-4 autonomous trucks system will utilize 100% automotive-grade components, reducing the bill-of-materials (BOM) cost per vehicle by approximately 70% compared to the previous generation. By leveraging the majority of components from the latest-generation Robotaxi solution, the system is designed for a service life of 20,000 hours, supporting up to 1 million kilometers of freight operation.

The first two models will be built on battery-electric vehicle platforms. These models are designed for mass production on the thousand-unit scale, with initial fleet deployment expected in 2026.

By adopting the fully redundant design and safety standards utilized in Pony.ai’s latest generation Robotaxi, the Gen-4 autonomous trucks will elevate the safety and reliability of autonomous freight transport to a new level. They will be equipped with a fully redundant drive-by-wire chassis, featuring comprehensive redundancy across six key systems—steering, braking, communication, power supply, computing, and sensors—ensuring safe operation under various conditions. These trucks will also undergo rigorous testing, including electromagnetic compatibility, reliability, high-temperature, and extreme-cold tests, to handle complex road conditions and harsh weather commonly encountered in freight scenarios, further enhancing safety.

China, the world’s largest long-haul trucking market, is accelerating its transition toward intelligent logistics. Upon deployment, the Gen-4 autonomous trucks are expected to significantly lower costs and increase efficiency in freight logistics. For example, the “1+4” platooning solution, where one lead truck is human-driven followed by four driverless trucks, is projected to reduce freight cost per kilometer by 29% and increase profit margin by 195% compared to traditional freight, based on current trial scenarios. In addition, it is projected to reduce per-vehicle carbon emissions by about 60 tons annually, setting new industry benchmarks in safety, efficiency, and sustainability.

Since entering the autonomous truck market in 2018, Pony.ai has expanded its fleet to around 200 trucks, accumulated over 1 billion ton-kilometers of freight transport, and secured the first or among the first autonomous truck road test permits and freight transport operation licenses in multiple regions across China. 

 

Lynk Pharmaceuticals Announces Key Phase II Clinical Results of LNK01004 for the Treatment of Patients with Moderate-to-Severe Atopic Dermatitis

By
Advertorial Desk
-

HANGZHOU, China and SHANGHAI and BOSTON, Nov. 19, 2025 /PRNewswire/ — Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as “Lynk Pharmaceuticals”), a clinical-stage innovative drug development company, today announced key results from its Phase II clinical trial of LNK01004, a skin restricted, soft pan-JAK inhibitor, for the treatment of atopic dermatitis (AD).

This randomized, double-blind, vehicle-controlled Phase II study evaluated the efficacy and safety of topical LNK01004 ointment (0.3% and 1.0%) in adult patients with moderate-to-severe AD. A total of 75 patients were enrolled and randomized in a 1:1:1 ratio to receive LNK01004 0.3%, LNK01004 1.0%, or vehicle ointment twice daily (BID) for 8 weeks. Eligible patients had a vIGA-AD score of 3 or 4 and BSA involvement between 5% and 35%.

Efficacy results demonstrated that after 8 weeks of treatment, both LNK01004 dose groups achieved higher EASI-75 response rates than the vehicle group, with more pronounced benefits in patients with higher baseline BSA. Among patients with BSA ≥10%, the EASI-75 response rates for the 0.3%, 1.0%, and vehicle groups were 61.1%, 46.2%, and 20% respectively. The vIGA-AD (score 0/1 with ≥2-point improvement) response rates were 44.4%, 38.5%, and 10%, respectively. In patients with BSA ≥20%, both LNK01004 groups showed even greater clinical improvements, further supporting its potential as a treatment for moderate-to-severe AD.

Safety results showed low systemic exposure following topical administration, with mean Cmax values of 0.06 ng/mL and 0.15 ng/mL for the 0.3% and 1.0% groups respectively, hundreds of times lower than the human whole-blood IC50. LNK01004 demonstrated good overall tolerability at both doses, consistent with findings from earlier studies. All treatment-related adverse events (TRAEs) were mild or moderate (Grade 1–2), and no treatment-related serious adverse events (SAEs) were observed.

Dr. Henry Wu, Chief Development Officer of Lynk Pharmaceuticals, said: “The Phase II results for LNK01004 demonstrated encouraging efficacy and favorable safety in patients with moderate-to-severe atopic dermatitis, particularly in those with larger affected areas or more severe disease. These findings highlight LNK01004 as a promising topical JAK inhibitor and underscore its potential clinical value in dermatologic indications.”

“Current treatment options for moderate-to-severe atopic dermatitis often rely on systemic therapies,” said Dr. Zhao-Kui (ZK) Wan, Chairman and CEO of Lynk Pharmaceuticals. “LNK01004, as a topical formulation, no systemic immunosuppression–related adverse reactions were observed in clinical studies, demonstrating good safety and compliance, as well as improvement in patients’ quality of life. We will continue advancing its clinical development in AD and other indications to bring more innovative treatment options to patients with dermatological diseases worldwide.”

About Lynk Pharmaceuticals:

Lynk Pharmaceuticals, a clinical stage company, was founded by senior drug R&D experts and executives from Pfizer, Merck, and Johnson & Johnson. Lynk Pharmaceuticals is dedicated to the discovery and development of innovative drugs for the treatment of immune and inflammatory diseases. Driven by a higher goal, Lynk Pharmaceuticals aims to be a market leader to address unmet medical demands by the development of innovative therapies. We thrive to provide differentiated innovative therapies to benefit patients globally. To date, Lynk Pharmaceuticals has independently developed several innovative new drug candidates and successfully completed a number of clinical studies. For more information about Lynk Pharmaceuticals, please visit: https://www.lynkpharma.com.

Nongshim Reveals Global Shin Ramyun Ad Featuring ‘aespa’

By
Advertorial Desk
-

SEOUL, South Korea, Nov. 19, 2025 /PRNewswire/ — Nongshim has appointed the K-pop group aespa as the new Global Brand Ambassador for Shin Ramyun, marking the first time the brand has selected a worldwide representative. As influential global artists, aespa will help communicate the slogan ‘Spicy Happiness In Noodles’ and introduce Shin Ramyun’s signature taste, identity, and cultural appeal to audiences across major international markets.

Nongshim Shin Ramyun Global Ambassador, aespa
Nongshim Shin Ramyun Global Ambassador, aespa

A Nongshim representative stated “aespa’s strong cultural presence, authentic global reach, and ongoing engagement with Shin Ramyun and Chapagetti since 2021 made the group a natural and compelling ambassador for the brand’s next stage of global expansion.”

  • Global Shin Ramyun Commercial

Nongshim has released a new commercial featuring aespa on its official global YouTube channel. Produced in a music-video format, the film highlights the group’s vocals, performance style, and artistic identity.

The campaign song (or background music) for the commercial is aespa’s rendition of “Spice Up Your Life,” the iconic 1997 hit by the renowned British pop group Spice Girls, reinterpreted with the group’s signature charm. The commercial conveys the message of delivering the “spicy happiness” of Shin Ramyun to consumers around the world.

The commercial captures lively and joyful reactions from consumers and emphasizes how Shin Ramyun delivers a universally enjoyable experience. It also includes an original ‘Shin Ramyun Dance, featuring movements inspired by opening the package, adding water, preparing chopsticks, and finger gestures that represent each letter of ‘SHIN’. The commercial will be released across major overseas regions, including the United States, China, Japan, Europe, and Southeast Asia.

  • Shin Ramyun × aespa Special Package Promotion

Nongshim will also introduce a special ‘aespa Special Package’of Shin Ramyun. The multi-pack will feature a group image of aespa, while single packs will showcase individual members. The package will be launched in China in November, followed by a global rollout including Korea.

In addition, selected Shin Ramyun and Shin Ramyun Toomba multi-packs will include photocards with member photos, handwritten messages, and QR codes linking to exclusive behind-the-scenes videos.

Additional offline activations are planned including branded pop-up experiences and various in-store promotions across global retail channels.

aespa commented, “Shin Ramyun has always been a brand we enjoy in our daily lives, whether on broadcasts or during tours. We’re excited to move from enjoying the product to officially representing it, and we look forward to sharing its appeal with fans around the world.”

Shin Ramyun Global Ad

Nongshim Shin Ramyun Global Ambassador, aespa
Nongshim Shin Ramyun Global Ambassador, aespa

EDMI and Bluecurrent extend partnership to drive intelligent grid transformation across Australia and New Zealand

By
Advertorial Desk
-

BRISBANE, Australia, Nov. 19, 2025 /PRNewswire/ — Global intelligent energy solutions leader EDMI has announced a long-term partnership renewal with Bluecurrent, a leading smart metering and digital services company. The agreement extends a collaboration spanning more than two decades, reaffirming EDMI’s commitment to intelligent, resilient, and data-driven grid solutions across the region.

The collaboration marks one of the first large-scale intelligent grid deployments in Australia, signalling how multi-utility data and edge intelligence are becoming integral to modern grid management. It represents a milestone in the evolution of connected, interoperable energy infrastructure across Australia and New Zealand.

Under the agreement, EDMI will deliver an integrated suite of grid and edge intelligence solutions powered by its NEOS platform, supporting multi-utility revenue metering, intelligent demand response, outage management, and distributed energy resource management (DERMS). Together, these capabilities enable real-time visibility, control, and optimisation across distributed energy networks.

The agreement comes at a time when Australia is entering a new phase of regulatory reform that will accelerate smart meter rollouts through 2030. As volumes increase, metering coordinators are ready to ensure secure, interoperable, and future-ready systems that can adapt to dynamic grid demands. By partnering, EDMI and Bluecurrent are laying the digital foundations for a more connected, flexible, and resilient energy future.

“Partnering with Bluecurrent allows us to extend our multi-utility intelligence platform deeper across the region,” said Roy Kirsopp, Group Chief Executive Officer at EDMI. “Connected metering infrastructure is the foundation of the energy transition, empowering utilities to measure more, understand faster, and act with confidence. Together, we’re scaling the next generation of intelligent grids.”

Richard Fink, Acting chief executive at Bluecurrent, said “This long-term partnership gives us the flexibility, reliability, and digital confidence we need as the smart meter rollout accelerates across Australia. Continuing to work with EDMI reinforces our ability to continue serving our customers securely, efficiently, and sustainably as the industry embraces intelligent grid technologies.”

This partnership underscores a shared commitment to supporting utilities, regulators, and consumers through the energy transition, combining EDMI’s intelligent grid expertise and proven technology with Bluecurrent’s market leadership and operational excellence.

About EDMI

EDMI is a global leader in providing intelligent energy solutions, dedicated to solving the unique challenges faced by the world’s most successful utilities. Our comprehensive range of smart metering and control products, combined with advanced communications and software offerings, enables us to deliver integrated end-to-end solutions tailored to our customers’ needs.

EDMI is owned by Osaki Electric Co., Ltd, a leading Japanese metering solutions provider listed on the Prime Market of the Tokyo Stock Exchange. To learn more about EDMI, visit the EDMI website at www.edmi-meters.com.

About Bluecurrent

Bluecurrent is a leading smart metering and digital services company, operating across Australasia with 2.7 million electricity, gas and water meters, processing more than 2 billion intervals of data a day. Our smart metering data unlocks information, influences behaviour and enables decision making for an electrified, renewable future.

Our purpose of unleashing smarter futures today, for a more sustainable tomorrow, is at the centre of everything we do. In June 2025 we achieved Scientific Business Target initiative (SBTi) verification of our carbon emission reduction near term and net zero targets. Bluecurrent is owned by Vector Ltd and Queensland Investment Corporation (QIC). Visit Bluecurrent’s website at bluecurrent.com.au

WEKA Unveils Next-Gen WEKApod Appliances to Redefine AI Storage Economics

By
Advertorial Desk
-

Powered by AlloyFlash, WEKApod Prime Delivers Breakthrough Cost Efficiency with 65% Better Price-Performance; WEKApod Nitro Offers Unprecedented Performance Density with 2x Faster Speeds for Demanding AI Workloads

ST. LOUIS and CAMPBELL, Calif., Nov. 19, 2025 /PRNewswire/ — From SC25: WEKA, the AI storage company, announced the next generation of its WEKApod™ appliances to upend traditional performance-versus-cost trade-offs. The completely redesigned WEKApod Prime appliance achieves 65% better price-performance by intelligently placing data across mixed flash configurations, delivering breakthrough economics without compromise. WEKApod Nitro doubles performance density with refreshed hardware, enabling organizations to accelerate AI and high-performance computing (HPC) innovation, maximize GPU utilization, and serve more customers. Its higher-density design also makes it ideal for large-scale object storage repositories and AI data lakes that demand performance without compromise.

WEKA Unveils Next-Gen WEKApod Appliances to Redefine AI Storage Economics
WEKA Unveils Next-Gen WEKApod Appliances to Redefine AI Storage Economics

WEKApod appliances are the easiest and fastest way to deploy and scale NeuralMesh™ by WEKA, the world’s only storage system purpose-built to accelerate AI at scale. WEKApod delivers NeuralMesh’s software-defined flexibility in ready-to-deploy, pre-validated configurations with a significantly improved setup utility with a plug-and-play experience. Organizations can start with as few as eight servers and scale to hundreds as their deployments grow, eliminating complex integration work while accessing NeuralMesh’s complete enterprise feature set—including distributed data protection, instant snapshots, multi-protocol access, automated tiering, encryption, and hybrid cloud capabilities.

The Infrastructure Efficiency Crisis
Organizations investing in AI infrastructure face mounting pressure to demonstrate ROI as valuable GPU resources sit underutilized, training cycles extend timelines, inference costs consume margins, and cloud bills spiral with data growth. Traditional storage systems force an impossible choice: extreme performance or manageable costs, never both. Meanwhile, datacenter constraints—limited rack space, power budgets, and cooling capacity—mean every rack unit must deliver more capability or infrastructure costs spiral out of control.

The next-generation WEKApod family directly addresses these business challenges head-on. WEKApod Prime eliminates the forced trade-off between performance and cost, delivering 65% better price-performance through intelligent data placement that automatically optimizes placement based on workload characteristics—ensuring writes maintain full performance while achieving breakthrough economics.

Now AI Builders and Cloud Providers Can Eliminate the Performance-Cost Trade-off

WEKApod Prime: offers a unique approach to mixed-flash technology, intelligently combining TLC and eTLC flash drives in configurations supporting up to 20 drives in a 1U rack or 40 drives in a 2U rack configuration. Unlike traditional tiered storage solutions that introduce cache hierarchies, data movement between tiers, and write performance penalties, WEKApod’s AlloyFlash delivers consistent performance across all operations—including full write performance without throttling—while achieving breakthrough economics. No compromises, no write-performance penalties, no cache hierarchies. WEKApod Prime is already being used by leading AI cloud pioneers like the Danish Centre for AI Innovation (DCAI).

The result is exceptional density that directly addresses datacenter resource constraints: 4.6x better capacity density, 5x better write IOPS per rack unit (versus previous generation), 4x better power density at 23,000 IOPS per kW (or 1.6 PB per kW), and 68% less power consumption per terabyte while maintaining the extreme performance AI workloads demand. For write-intensive AI workloads like training and checkpointing, this means storage keeps pace without performance penalties that can idle expensive GPUs during critical operations.

WEKApod Nitro: purpose-built for AI factories running hundreds or thousands of GPUs, delivers 2x faster performance and 60% better price-performance through upgraded hardware, including NVIDIA ConnectX-8 SuperNIC, delivering 800 Gb/s throughput and 20 TLC drives in a compact 1U form factor. As turnkey NVIDIA DGX SuperPOD and NVIDIA Cloud Partner (NCP)-certified appliances, both WEKApod configurations eliminate weeks of integration work, allowing organizations to bring customer services to market in days rather than months while ensuring storage infrastructure keeps pace with next-generation accelerators.

Measurable Business Impact Across AI Deployments

  • For AI Cloud Providers and Neoclouds: Serve more customers profitably with existing infrastructure while maintaining guaranteed performance SLAs. The 65% improvement in price-to-performance directly translates into higher margins for GPU-as-a-service offerings. Faster deployment times mean faster time-to-revenue for new customers.
  • For Enterprises Deploying AI Factories: Deploy AI initiatives in days, not months, with turnkey solutions that eliminate complex integration work, enabling IT teams to achieve enterprise-grade storage performance without specialized expertise. Reduce power consumption by up to 68% through improved density and efficiency, while scaling AI capabilities without proportional increases in datacenter footprint, power, or cooling requirements—delivering measurable infrastructure ROI from day one.
  • For AI Builders and Researchers: Accelerate model development with GPU utilization rates exceeding 90%. Reduce training time to accelerate iteration cycles and gain a competitive advantage. Lower inference costs that make new AI applications economically viable. Start with as few as eight servers and scale to hundreds as needs grow, with complete NeuralMesh enterprise features included by default.

AI infrastructure providers are already seeing direct business impact from these innovations:

“Space and power are the new limits of innovation in data centres. WEKApod’s exceptional storage performance density allows us to deliver hyperscaler-level data throughput and efficiency within an optimised footprint—unlocking more AI capability per kilowatt and square metre,” said Nadia Carlsten, CEO, Danish Centre for AI Innovation (DCAI). “This efficiency directly improves economics and accelerates how we bring AI innovation to our customers.”

“AI investments must demonstrate ROI. WEKApod Prime delivers 65% better price-performance without compromising on speed, while WEKApod Nitro doubles performance to maximize GPU utilization. The result: faster model development, higher inference throughput, and better returns on compute investments that directly impact profitability and time-to-market,” said Ajay Singh, Chief Product Officer at WEKA.

“Networking is essential to AI infrastructure, transforming AI compute and storage into a thinking platform that generates and delivers tokens of digital intelligence at scale,” said Kevin Deierling, senior vice president of Networking at NVIDIA. “With NVIDIA Spectrum-X Ethernet and NVIDIA ConnectX-8 networking at the foundation of WEKApod, WEKA is helping enterprises eliminate data bottlenecks— which is critical to optimize AI performance.”

Availability

Next-generation WEKApod appliances are available now. Organizations can learn more at weka.io/wekapod or visit WEKA at SuperComputing 2025, booth #2215.

About WEKA

WEKA is transforming how organizations build, run, and scale AI workflows with NeuralMesh™ by WEKA®, its intelligent, adaptive mesh storage system. Unlike traditional data infrastructure, which becomes slower and more fragile as workloads expand, NeuralMesh becomes faster, stronger, and more efficient as it scales, dynamically adapting to AI environments to provide a flexible foundation for enterprise AI and agentic AI innovation. Trusted by 30% of the Fortune 50, NeuralMesh helps leading enterprises, AI cloud providers, and AI builders optimize GPUs, scale AI faster, and reduce innovation costs. Learn more at www.weka.io or connect with us on LinkedIn and X.

WEKA and the W logo are registered trademarks of WekaIO, Inc. Other trade names herein may be trademarks of their respective owners.


 

Rafa Laboratories Awarded up to $186 Million by BARDA to Develop a Life-Saving Intramuscular TXA Injection for Prehospital Care

By
Advertorial Desk
-

JERUSALEM, Nov. 19, 2025 /PRNewswire/ — Rafa Laboratories, a global leader in Chemical, Biological, Radiological, and Nuclear hazards medical countermeasures and Biodefense, today announced it has been awarded with a landmark development contract by the Biomedical Advanced Research and Development Authority (BARDA), part of Administration for Strategic Preparedness and Response  at the U.S. Department of Health and Human Services (HHS), for the advanced development of a novel intramuscular (IM) formulation of tranexamic acid (TXA)—a potentially life-saving therapy for uncontrolled bleeding. The contract is valued at up to $186 million, including all option periods.

This pivotal collaboration, which represents Rafa’s second major contract with BARDA, addresses an urgent global need: a rapidly deployable, easy-to-administer treatment for hemorrhage in the critical prehospital setting.

 Addressing the Critical Window to Save Lives

Uncontrolled bleeding is the leading cause of preventable death following trauma, whether caused by accidents, mass-casualty events or in the battlefield. Caregivers need a tool which can be easily administered to a large number of casualties in a short period of time. TXA is an antifibrinolytic agent commonly used off label around the world to treat trauma bleeding in the pre-hospital and hospital space.

Landmark clinical studies performed in tens of thousands of individuals have demonstrated that TXA can significantly reduce mortality rates if administered quickly enough following trauma hemorrhagic injury.

“The clock starts ticking the moment a patient sustains a hemorrhagic injury, and the few minutes before reaching a hospital are the most critical ones,” said Roy Shay, Vice President of Biodefense at Rafa Laboratories. “Currently, TXA is typically administered intravenously (IV), which is challenging, time-consuming and requires training.  The need for trained individuals even greater in high-stress, or mass-casualty situations. Developing a new intramuscular TXA injection is a potential game-changer as it simplifies the administration process, especially if administered with an autoinjector.

As planned under the potential scope of this project, Rafa shall also develop a TXA autoinjector which will enable  professional as well as nonprofessional care givers to deliver this essential treatment instantly—dramatically increasing survival chances worldwide.”

“The IM route offers a fast, reliable, and user-friendly alternative for the existing IV administration, which can be extremely difficult in patients experiencing severe shock”.

BARDA and Rafa are Collaborating on a Comprehensive Development Approach

Rafa Laboratoriesis adopting a robust and integrated product development approach, which is planned to include formulation development, manufacturing scale-up, pre/clinical trials and a streamlined regulatory pathway designed to secure U.S. Food and Drug Administration (FDA) approval.

“Over the past four decades, Rafa has built a reputation for developing highly dependable medical countermeasures targeting acute, life-threatening conditions, mainly CBRN and pain management.” said Iddo Leshem, Chief Executive Officer of Rafa Laboratories. “The IM TXA development contract marks a strategic expansion of Rafa’s presence in acute trauma care. We are deeply committed to partnering with BARDA to accelerate the delivery of this urgently needed, life-saving solution to hundreds of thousands of patients across the globe”.

About Rafa Laboratories

Founded in 1937 and headquartered in Jerusalem, Israel, Rafa Laboratories is a global leader in biodefense and emergency medical solutions. For more than 40 years, Rafa has supplied medical countermeasure autoinjectors to the U.S. federal government, NATO allies, military forces, and civilian stockpiles worldwide, including its Midazolam 10 mg autoinjector (US-FDA approved under NDA #216359 since 2022) and Atropine autoinjector (US-FDA approved under NDA #212319 for 2 mg since 2018 and EUA # for 0.5 & 1 mg since 2017). The company’s expertise spans the entire value chain — from a robust R&D pipeline addressing emerging threats, to cGMP-compliant manufacturing and successful regulatory approvals from the U.S. FDA and European health authorities.

Rafa’s controlling shareholder, FIMI Opportunity Funds, is Israel’s leading private equity fund. With over 25 years of experience, FIMI manages assets of $7 billion and has completed nearly 100 investments globally.

This project has been supported in whole or in part with federal funds from the U.S. Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA), under contract number  75A50125C00018.

Media Contact:
Roy Shay
VP, Biodefense
Rafa Laboratories
roys@rafa.co.il 

 

1...1,9031,9041,905...6,599Page 1,904 of 6,599